Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy [EARLY_Phase 1]
This early-phase study evaluated imaging approaches (BOLD MRI and FMISO PET) to assess the hypoxic tumor microenvironment in patients with h…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Study of INCB086550 in Select Solid Tumors [Phase 2]
A Phase 2 trial evaluating INCB086550 across select solid tumors, including non-small cell lung cancer and urothelial carcinoma, was termina…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Case-Control Study of the Glycotest™ HCC Panel Vs AFP for the Detection of Early-stage Hepatocellular Carcinoma
ClinicalTrials.gov entry for a case-control study comparing the Glycotest HCC Panel to AFP for early detection of hepatocellular carcinoma; …
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Anti-PD-1 Antibody AK105 in Patients With Selected Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial AK105 in selected advanced solid tumors has completed Phase 1/2; the summary does not provide efficacy or safety results.
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: PM8002 in Combination With Chemotherapy as First Line Therapy in Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial evaluating PM8002 in combination with chemotherapy as first-line therapy for hepatocellular carcinoma; the study is c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy [Phase 2]
A Phase 2 neoadjuvant trial comparing atezolizumab/bevacizumab versus neoadjuvant radiation therapy in hepatocellular carcinoma with portal …
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: Preliminary Antitumor Activity, Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular Carcinoma [Phase 2]
Phase 2 study evaluating the combination of tislelizumab and lenvatinib in hepatocellular carcinoma, reporting preliminary antitumor activit…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer [Phase 1]
This first-in-human Phase 1 trial reports safety, tolerability, and preliminary antitumor activity of MTL-CEBPA in patients with advanced he…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer [NA]
A clinical trial evaluating stereotactic body radiation therapy for hepatocellular carcinoma has terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone [Phase 2]
Randomized Phase II trial comparing MTL-CEBPA plus Sorafenib to Sorafenib alone in hepatocellular carcinoma; the study includes patients wit…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.
This post-approval study by Boston Scientific evaluates methods to calculate the radiation-absorbed dose of Tc-99m MAA when used with TheraS…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer [Phase 1]
A first-in-human Phase 1 study of TORL-4-500 for advanced cancers is currently recruiting, including hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: TACE Combined with Anti-PD-1 Antibody in Patients with Advanced Hepatocellular Carcinoma [Phase 2]
A Phase 2 trial evaluating transarterial chemoembolization (TACE) combined with an anti-PD-1 antibody for advanced hepatocellular carcinoma …
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Evaluate the Effect of Tirazamine on Primary Liver Cancer. [Phase 1, Phase 2]
A Phase 1/2 trial evaluating tirazamine for hepatocellular carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT [Phase 3]
A Phase III randomized trial comparing radiotherapy plus toripalimab against sorafenib in advanced hepatocellular carcinoma with portal vein…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Nivolumab in Combination With TACE/TAE for Patients With Intermediate Stage HCC [Phase 2, Phase 3]
The study evaluating nivolumab in combination with transarterial chemoembolization/chemoembolization for intermediate-stage hepatocellular c…
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma [Phase 3]
The Phase 3 trial comparing Seocalcitol to placebo for adjuvant treatment of hepatocellular carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma [NA]
A trial evaluating Seocalcitol versus placebo in advanced hepatocellular carcinoma was terminated.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Study Investigating the Efficacy and Safety of Ociperlimab and Tislelizumab and BAT1706 Combinations in Patients With Advanced HCC [Phase 2]
Phase 2 study evaluating a triple combination of Ociperlimab, Tislelizumab, and BAT1706 in advanced hepatocellular carcinoma has completed w…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR) [Phase 1]
The Phase 1 trial of glypican-3–specific CAR-T cells (GLYCAR) for hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC) [Phase 3]
Phase III trial evaluating AK105 injection plus Anlotinib hydrochloride capsules versus Sorafenib for advanced hepatocellular carcinoma; the…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: An Investigational Scan (Magnetic Resonance Elastography) in Detecting Treatment Response in Patients With Advanced Liver Cancer [NA]
This completed clinical trial evaluated magnetic resonance elastography as an investigational method to detect treatment response in patient…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Deep Learning Image Reconstruction for Abdominal CT of Hepatocellular Carcinoma Compared With 3-TESLA MRI
A completed clinical trial evaluating deep learning image reconstruction for abdominal CT in hepatocellular carcinoma and comparing it with …
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors [Phase 1]
Phase 1 interventional trial evaluating INCB 99280 in combination with ipilimumab in select solid tumors has been terminated. The study, spo…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: NeuWave Microwave Ablation HCC China Study [NA]
Completed clinical trial evaluating NeuWave Microwave Ablation for hepatocellular carcinoma in China; results were posted on 2025-02-14.